Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0027627 (
metastases
)
103,950
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
In a prospective study the predictive value of a multivariate morphometric prognostic index was evaluated in 195 patients with primary breast cancer who had not been treated with any form of chemotherapy or hormonal treatment. The presence or absence of distant tumour recurrence combined with the scores of the prognostic index were compared with the survival curves predicted in a previous study. The value of the presence of lymph node
metastases
, number of positive nodes, tumour size, mitotic activity index, and
oestrogen receptor
status in prediction of prognosis were also investigated. In agreement with the results of the previous retrospective study, the prospective use of the index had the strongest predictive prognostic value, followed by the mitotic activity index. Statistical analysis showed that the actual prognoses of 43 of the 195 patients (22%) were more accurately determined by the prognostic index rather than by using the presence of the lymph node
metastases
as the classifying variable. The prognostic index is consistently reproducible by different technicians; it is a reliable method of predicting distant recurrence of tumour and hence the prognosis of patients with primary breast carcinoma. It provides more prognostic information than the presence of lymph node
metastases
alone, and the index should be incorporated in routine pathology reports.
...
PMID:Prospective evaluation of prognostic value of morphometry in patients with primary breast cancer. 199 47
Fifty-four intracranial neoplasms (29 meningiomas, 16 gliomas, seven acoustic neuromas and two cerebral
metastases
) and nine specimens of normal brain were evaluated for specific progesterone and
oestrogen receptor
proteins using a dextran-coated charcoal assay and Scatchard plot analysis. Sixteen meningiomas (55%) were progesterone receptor (PgR) positive (median 52; mean 120; range 10-486 fmol mg-1 cytosol protein), whilst all were
oestrogen receptor
negative (ER-). Two (28%) of the acoustic neuromas contained small amounts of PgR protein, but all seven were ER-. None of the gliomas, cerebral
metastases
or specimens of normal brain contained ER or PgR protein. Analysis of PgR status and clinicopathological data suggest that there is no predictive correlation between PgR status and the patients age, sex, reproductive status, tumour histology or tumour behaviour. These results again suggest that in meningiomas PgR proteins are not modulated by oestrogens acting through ER. This finding may explain the failure of antioestrogen therapy to influence the growth of meningiomas. The significance of PgR protein in intracranial meningiomas is discussed with respect to tumour heterogeneity and implications for research with gene probes.
...
PMID:Sex hormone receptors in intracranial tumours and normal brain. 362 83
The prognostic value of clinical, quantitative, and qualitative microscopical features of both the primary tumour and also of the affected lymph nodes were investigated in 71 patients with breast cancer with spread to lymph nodes (T X N + M0). Age, tumour size, and localisation of the tumour comprised the clinical features; morphometry included assessment of the cellularity index, the mitotic activity index, and seven nuclear indices; the qualitative features investigated were histological type and grade, nuclear grade,
oestrogen receptor
content, number of lymph nodes affected, capsule infiltration of the nodes, presence of metastatic deposits in the efferent lymph vessels, percentage area of lymph node occupied by tumour. Immunohistochemistry was performed to show the presence of carcinoembryonic antigen and peanut agglutinin. All the patients had a minimum follow up of 24 months (maximum 48 months, mean 36 months). Analysis of the results showed that the combined results of morphometry (of the primary tumour and the axillary lymph node metastatic deposits) yielded more information than analysis of axillary lymph node state, or morphometry of the primary tumour, or the lymph node
metastases
alone. Patients with a nuclear axes ratio of greater than 1.41 in the primary tumour and greater than 1.36 in the lymph node metastatic deposits were less likely to develop distant
metastases
than patients with values below any of these thresholds (recurrence rates 5.2% and 46%, respectively). Thus the preliminary results of this prospective study indicate that morphometry provides important prognostic information in patients with breast cancer that has spread to lymph nodes.
...
PMID:Morphometry and breast cancer. II. Characterisation of breast cancer cells with high malignant potential in patients with spread to lymph nodes: preliminary results. 372 13
This study investigates a series of factors, all recordable by the time of presentation of distant
metastases
from primary breast cancer and relates these to survival after the initiation of endocrine therapies. One hundred and ninety-one patients have received endocrine therapy as initial treatment for distant
metastases
. In all patients both the histological grade and
oestrogen receptor
(ER) status of primary tumour tissue; the lymph node stage and menopausal status at mastectomy and the disease-free interval and sites of initial
metastases
are available for analysis. Four of these factors have been found to contribute independently towards prolonged survival after the initiation of treatment: tumour grade, ER status, disease-free interval and sites of
metastases
. Employing a multivariate analysis incorporating these four factors, three groups of patients have been identified with survivals of 67, 37 and 0 per cent at 18 months on therapy. These three groups of patients contain 37, 41 and 22 per cent of the patient population respectively.
...
PMID:Survival patterns in hormone treated advanced breast cancer. 375 43
The importance of the presence of hormone receptors of cells derived from breast cancer tissue for the duration of the relapse-free interval was evaluated in 41 patients with stage II breast cancer. After modified radical mastectomy with axillary lymphadenectomy the patients received radiotherapy and adjuvant polychemotherapy and/or hormone therapy. There was no indication of
metastases
in any patient at the time of operation. There was a significant correlation of the relapse-free interval to tumor size (p less than 0.05), to the number of involved lymph nodes (p less than 0.0005), and also to the presence of the progesterone receptor (PgR), which seemed to play a more important role in this context than the
oestrogen receptor
(ER) (p less than 0.001). We conclude from this study that the evaluation of the PgR in breast cancer cells is important for the prognosis of the duration of the relapse-free interval.
...
PMID:[Significance of hormone receptors of breast cancer cells for the duration of a disease-free interval]. 401 43
Serum carcinoembryonic antigen concentrations (serum CEA) in 80 patients with primary breast cancer were measured preoperatively, one month after operation, and thereafter serially every third month. These data were related to histological and morphometric features of the primary breast carcinoma and the lymph node
metastases
and to clinical follow up data. Analysis of the serum CEA values showed significant correlations with size of tumour, the presence of lymph node
metastases
,
oestrogen receptor
, and occurrence of distant
metastases
. Furthermore, the results indicated that serial determination of serum CEA in the first two years after operation may be useful in monitoring for the occurrence of distant
metastases
in patients with metastatic spread to lymph nodes and with large (greater than or equal to 2 cm) primary breast tumours positive for
oestrogen receptor
. In agreement with other studies, however, it was found that the predictive value of serum CEA concentrations in general is weak and costs may prohibit the implementation of the routine assessment of CEA concentrations.
...
PMID:Monitoring serum CEA in women with primary breast tumours positive for oestrogen receptor and with spread to lymph nodes. 406 82
In a group of 335 patients with primary breast carcinoma the presence of immunoreactive carcinoembryonic antigen (CEA) and the binding of the lectin peanut agglutinin (PNA) in the primary carcinoma and in axillary lymph node
metastases
were investigated. The correlation between these results and a variety of established clinical, histopathologic, morphometric and biochemical prognosticators was studied. These features included lymph node status, tumour diameter, tumour type, nuclear grade, histologic grade,
oestrogen receptor
status, mitotic activity index and a number of nuclear measurements. The results indicate that CEA immunoreactivity of and PNA binding to tumour cells in primary breast carcinomas or lymph node
metastases
do not correlate with established prognostic factors in breast cancer.
...
PMID:Carcinoembryonic antigen expression and peanut agglutinin binding in primary breast cancer and lymph node metastases; lack of correlation with clinical, histopathological, biochemical and morphometric features. 408 79
The biological and metastatic properties of cells from a murine mammary adenocarcinoma, MT1, were studied during serial transplantation in syngeneic hosts. Over 35 generations the tumour progressed from a well-differentiated, poorly metastatic neoplasm to an anaplastic highly metastatic state. At early passages the tumour yielded uniform cultures of cuboidal epithelial cells, at passage 17 both epitheloid and spindle type cells were present, and by passage 30 only spindle type cells were obtained. Epithelioid cell lines and clones when injected intravenously into syngeneic hosts produced lung colonies only, whereas spindle cell lines were capable of extensive extrapulmonary colonisation. Similar patterns of dissemination and growth were seen in spontaneous metastasis assays. In spite of the marked phenotypic differences in these 'subpopulations', their comparable ultrastructural features,
oestrogen receptor
levels, expression of MMTV antigens, DNA content and lectin binding profiles suggested a common cell lineage. It is proposed that these cell lines will be of use in the determination of tumour and host factors influencing tumour progression and the evolution of metastatic potential.
Clin Exp
Metastasis
PMID:Studies of mammary carcinoma metastasis in a mouse model system. I: Derivation and characterization of cells with different metastatic properties during tumour progression in vivo. 608 22
The ploidy level was investigated by flow cytometric analysis in 143 cases of invasive intraductal mammary carcinoma. Aneuploidy was found in 70% of the tumours. Comparison of ploidy level with histopathologic features, hormone receptor status and clinical characteristics indicated that aneuploid tumours were mostly poorly differentiated (grade III) and
oestrogen receptor
negative (p less than 0.05). However, this applied only to postmenopausal patients. No correlation appeared between the progesterone receptor status and the ploidy level, but this parameter tended to predict the frequency of lymph node
metastases
. The possible prognostic significance of these findings is discussed.
...
PMID:Ploidy level of human breast carcinoma. Relation to histopathologic features and hormone receptor content. 633 Oct 77
Multiple
oestrogen receptor
assays have been performed on primary, locally recurrent, and metastatic breast cancer in 62 patients. A change in receptor status was found in seven of 25 late recurrences (28%). It was noted that the level of
oestrogen receptor
was higher in lymph nodes than the primary tumour, particularly at the time of initial surgery. Other factors which might contribute to differences in receptor levels include site of
metastases
, method of handling, heterogeneity of tumours, and subsequent treatment. Such differences have important implications in management.
...
PMID:Multiple or sequential oestrogen receptor assays in breast cancer. 657 74
<< Previous
1
2
3
4
5
6
7
8
9
10
Next >>